Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · February 17, 2022

Predicting Cognitive Decline in Older People With Type 2 Diabetes Through Baseline Inflammatory Marker Levels



Additional Info

Disclosure statements are available on the authors' profiles:

Higher baseline inflammatory marker levels predict greater cognitive decline in older people with type 2 diabetes: year 10 follow-up of the Edinburgh Type 2 Diabetes Study
Diabetologia 2022 Mar 01;65(3)467-476, AJ Sluiman, S McLachlan, RB Forster, MWJ Strachan, IJ Deary, JF Price

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading